71 related articles for article (PubMed ID: 24066618)
1. New method to identify non-small-cell lung cancer biomarker.
Hill R
Bioanalysis; 2013 Oct; 5(19):2337. PubMed ID: 24066618
[No Abstract] [Full Text] [Related]
2. [Application of immunohistochemistry in diagnosis of ALK-positive non-small cell lung cancer].
Du X; Zhou XY; Lü N; Li XH; Ying JM; Yang F; Li Y; Sun Y; Zhao M; Zhou LX
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):858-60. PubMed ID: 24507115
[No Abstract] [Full Text] [Related]
3. [Application of fluorescence in-situ hybridization in diagnosis of ALK-positive non-small cell lung cancer].
Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):854-6. PubMed ID: 24507113
[No Abstract] [Full Text] [Related]
4. [Consensus on dignosis for ALK positive non-small cell lung cancer in China, the 2013 version].
Zhang XC; Lu S; Zhang L; Wang CL; Cheng Y; Li GD; Mok T; Huang C; Liu XQ; Wang J; Wang MZ; Zhang YP; Zhou JY; Zhou XY; Lin DM; Yang JJ; Li H; Chen HQ; Zhong WZ; Wu YL
Zhonghua Bing Li Xue Za Zhi; 2013 Jun; 42(6):402-6. PubMed ID: 24060077
[No Abstract] [Full Text] [Related]
5. Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testing.
Wallander ML; Geiersbach KB; Tripp SR; Layfield LJ
Arch Pathol Lab Med; 2012 Jul; 136(7):796-803. PubMed ID: 22742552
[TBL] [Abstract][Full Text] [Related]
6. [New perspectives in the management of non-small-cell lung carcinoma (NSCLC)].
Brockmöller J; Junker K; Multhoff G
Onkologie; 2006 Sep; 29 Suppl 2():25-8. PubMed ID: 16974125
[No Abstract] [Full Text] [Related]
7. Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung.
Cagle PT; Sholl LM; Lindeman NI; Alsabeh R; Divaris DX; Foulis P; Lee G; Neal JW; Nowak JA; Yu PP;
Arch Pathol Lab Med; 2014 Feb; 138(2):171-4. PubMed ID: 23808401
[No Abstract] [Full Text] [Related]
8. Epidermal growth factor receptor biomarkers in non-small-cell lung cancer: a riddle, wrapped in a mystery, inside an enigma.
Shepherd FA; Tsao MS
J Clin Oncol; 2010 Feb; 28(6):903-5. PubMed ID: 20100955
[No Abstract] [Full Text] [Related]
9. Immunohistochemical detection of protein kinase C-beta (PKC-beta) in tumour specimens of patients with non-small cell lung cancer.
Lahn M; McClelland P; Ballard D; Mintze K; Thornton D; Sandusky G
Histopathology; 2006 Oct; 49(4):429-31. PubMed ID: 16978209
[No Abstract] [Full Text] [Related]
10. Selecting lung cancer patients for treatment with epidermal growth factor receptor tyrosine kinase inhibitors by immunohistochemistry and fluorescence in situ hybridization--why, when, and how?
Dziadziuszko R; Hirsch FR; Varella-Garcia M; Bunn PA
Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4409s-4415s. PubMed ID: 16857819
[TBL] [Abstract][Full Text] [Related]
11. Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.
Wikman H; Seppänen JK; Sarhadi VK; Kettunen E; Salmenkivi K; Kuosma E; Vainio-Siukola K; Nagy B; Karjalainen A; Sioris T; Salo J; Hollmén J; Knuutila S; Anttila S
J Pathol; 2004 May; 203(1):584-93. PubMed ID: 15095482
[TBL] [Abstract][Full Text] [Related]
12. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas: Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study.
Lee HJ; Xu X; Choe G; Chung DH; Seo JW; Lee JH; Lee CT; Jheon S; Sung SW; Chung JH
Lung Cancer; 2010 Jun; 68(3):375-82. PubMed ID: 19712993
[TBL] [Abstract][Full Text] [Related]
13. New challenges for laboratory diagnostics in non-small cell lung cancer.
Holdenrieder S; Stieber P
Cancer Biomark; 2010; 6(3-4):119-21. PubMed ID: 20660958
[No Abstract] [Full Text] [Related]
14. Gastrin-releasing peptide receptor expression in lung cancer.
Mattei J; Achcar RD; Cano CH; Macedo BR; Meurer L; Batlle BS; Groshong SD; Kulczynski JM; Roesler R; Dal Lago L; Brunetto AT; Schwartsmann G
Arch Pathol Lab Med; 2014 Jan; 138(1):98-104. PubMed ID: 24377816
[TBL] [Abstract][Full Text] [Related]
15. Experience in integrating ALK testing and crizotinib into the routine treatment of patients with non-small cell lung cancer.
Gautschi O; Schefer H; Riklin C; Strobel K; Diebold J
Onkologie; 2013; 36(6):342-7. PubMed ID: 23774148
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic relevance of overexpressed mRNA of novel oncogene with kinase-domain (NOK) in lung cancers.
Amachika T; Kobayashi D; Moriai R; Tsuji N; Watanabe N
Lung Cancer; 2007 Jun; 56(3):337-40. PubMed ID: 17298854
[TBL] [Abstract][Full Text] [Related]
17. bcl-2 protein in non-small-cell lung carcinoma.
Katz HR
N Engl J Med; 1994 Jan; 330(3):221. PubMed ID: 8264763
[No Abstract] [Full Text] [Related]
18. Identification of metastasis-associated receptor tyrosine kinases in non-small cell lung cancer.
Müller-Tidow C; Diederichs S; Bulk E; Pohle T; Steffen B; Schwäble J; Plewka S; Thomas M; Metzger R; Schneider PM; Brandts CH; Berdel WE; Serve H
Cancer Res; 2005 Mar; 65(5):1778-82. PubMed ID: 15753374
[TBL] [Abstract][Full Text] [Related]
19. [A new target in non-small cell lung cancer: ROS1 fusion gene].
Cai WJ; Su B
Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):1-4. PubMed ID: 23648291
[No Abstract] [Full Text] [Related]
20. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer.
Li R; Todd NW; Qiu Q; Fan T; Zhao RY; Rodgers WH; Fang HB; Katz RL; Stass SA; Jiang F
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):482-7. PubMed ID: 17255269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
